Home › Funds › Farallon Capital Management › LNTH

Farallon Capital Management position in LNTH

LANTHEUS HLDGS INC · Health Care

Farallon Capital Management reported holding 3,111,254 shares of LNTH (LANTHEUS HLDGS INC) in its Q3 2026 13F filing — a position valued at US$309.7M, representing 1.37% of its reported portfolio and ranking #22 among its reported holdings. Farallon Capital Management has disclosed LNTH holdings in 15 of the last 15 reported quarters, going back to Q1 2023.

Latest position (Q3 2026)3.11M sh
Reported value held$309.66M
Portfolio Weight1.37%
First reportedQ1 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Farallon Capital Management's LNTH position evolved

Farallon Capital Management first disclosed a stake in LNTH in Q1 2023 at 184,000 shares (US$15.2M). The position peaked in Q2 2026 at 5,583,479 shares, worth US$619.4M. Across 15 filings, Farallon Capital Management increased the stake 10 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,111,254 shares valued at US$309.7M — a reduction of -2,472,225 shares quarter over quarter.. Notable position changes include a 639% increase in Q2 2023 (shares fell 17% over the following quarter), a 87% trim in Q4 2023 (shares were roughly flat over the following quarter), a 595% increase in Q1 2024 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2023 184.00K $15.19M New
Q2 2023 1.36M $114.17M Add
Q3 2023 1.60M $111.06M Add
Q4 2023 213.33K $13.23M Reduce
Q1 2024 1.48M $92.32M Add
Q2 2024 2.28M $183.00M Add
Q3 2024 2.96M $324.34M Add
Q4 2024 5.32M $475.59M Add
Q1 2025 6.02M $587.87M Add
Q2 2025 6.72M $550.28M Add
Q3 2025 3.48M $178.35M Reduce
Q4 2025 5.43M $361.20M Add
Q1 2026 5.58M $423.51M Add
Q2 2026 5.58M $619.43M Hold
Q3 2026 3.11M $309.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LNTH and 13F data

LNTH (LANTHEUS HLDGS INC) is a Health Care company. 31 other funds we track also report a position in LNTH — the largest reported positions include Pentwater Capital Management LP (US$388.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$309.7M), LMR Partners LLP (US$209.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LNTH

All LNTH fund holders →

FAQ

How long has Farallon Capital Management held LNTH?

Farallon Capital Management has disclosed LNTH holdings in 15 of the last 15 reported quarters, going back to Q1 2023.

What is Farallon Capital Management's current position in LNTH?

As of Q3 2026, Farallon Capital Management holds 3.11M shares of LNTH (LANTHEUS HLDGS INC), valued at $309.66M, representing 1.37% of its reported portfolio and ranking #22.

Has Farallon Capital Management been buying or selling LNTH?

In the latest 13F filing (Q3 2026), Farallon Capital Management reduced its position in LNTH. The position peaked in Q2 2026 at 5.58M shares.

Which other funds hold LNTH?

Other major institutional holders of LNTH include Pentwater Capital Management LP, FARALLON CAPITAL MANAGEMENT, L.L.C., LMR Partners LLP, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.